Cargando…
Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinoma
Single-agent checkpoint inhibitor (CPI) activity in Epstein-Barr Virus (EBV) related nasopharyngeal carcinoma (NPC) is limited. Dual CPI shows increased activity in solid cancers. In this single-arm phase II trial (NCT03097939), 40 patients with recurrent/metastatic EBV-positive NPC who failed prior...
Autores principales: | Lim, Darren Wan-Teck, Kao, Hsiang-Fong, Suteja, Lisda, Li, Constance H., Quah, Hong Sheng, Tan, Daniel Shao-Weng, Tan, Sze-Huey, Tan, Eng-Huat, Tan, Wan-Ling, Lee, Justina Nadia, Wee, Felicia Yu-Ting, Jain, Amit, Goh, Boon-Cher, Chua, Melvin L. K., Liao, Bin-Chi, Ng, Quan Sing, Hong, Ruey-Long, Ang, Mei-Kim, Yeong, Joe Poh-Sheng, Iyer, N. Gopalakrishna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184620/ https://www.ncbi.nlm.nih.gov/pubmed/37188668 http://dx.doi.org/10.1038/s41467-023-38407-7 |
Ejemplares similares
-
Establishment and Characterization of Humanized Mouse NPC-PDX Model for Testing Immunotherapy
por: Liu, Wai Nam, et al.
Publicado: (2020) -
Analysis of T cell receptor clonotypes in tumor microenvironment identifies shared cancer-type-specific signatures
por: Teng, Yvonne H. F., et al.
Publicado: (2021) -
Correction to: Analysis of T cell receptor clonotypes in tumor microenvironment identifies shared cancer-type-specific signatures
por: Teng, Yvonne H. F., et al.
Publicado: (2021) -
Successful targeting of PD-1/PD-L1 with chimeric antigen receptor-natural killer cells and nivolumab in a humanized mouse cancer model
por: Liu, Wai Nam, et al.
Publicado: (2022) -
Association of clinical factors with survival outcomes in laryngeal squamous cell carcinoma (LSCC)
por: Fong, Pei Yuan, et al.
Publicado: (2019)